Trial Profile
A retrospective study of Riociguat used before balloon pulmonary angioplasty (BPA) in chronic thromboembolic pulmonary hypertension patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2017
Price :
$35
*
At a glance
- Drugs Riociguat (Primary)
- Indications Pulmonary hypertension
- Focus Therapeutic Use
- 30 Aug 2017 Results presented at the ESC Congress 2017: Annual Congress of the European Society of Cardiology
- 22 Jun 2016 New trial record
- 18 May 2016 Results presented at the 112th International Conference of the American Thoracic Society